BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 28630092)

  • 1. Characterization of High-Avidity Cytomegalovirus-Specific T Cells with Differential Tetramer Binding Coappearing after Allogeneic Stem Cell Transplantation.
    Ogonek J; Verma K; Schultze-Florey C; Varanasi P; Luther S; Schweier P; Kühnau W; Göhring G; Dammann E; Stadler M; Ganser A; Koehl U; Koenecke C; Weissinger EM; Hambach L
    J Immunol; 2017 Jul; 199(2):792-805. PubMed ID: 28630092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early detection of cytomegalovirus-specific cytotoxic T lymphocytes against cytomegalovirus antigenemia in human leukocyte antigen haploidentical hematopoietic stem cell transplantation.
    Kato R; Tamaki H; Ikegame K; Yoshihara S; Kaida K; Taniguchi K; Inoue T; Ishii S; Nakata J; Fujioka T; Eguchi R; Soma T; Okada M; Ogawa H
    Ann Hematol; 2015 Oct; 94(10):1707-15. PubMed ID: 26193851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible Impact of Cytomegalovirus-Specific CD8
    Ogonek J; Varanasi P; Luther S; Schweier P; Kühnau W; Göhring G; Dammann E; Stadler M; Ganser A; Borchers S; Koehl U; Weissinger EM; Hambach L
    Biol Blood Marrow Transplant; 2017 Jul; 23(7):1046-1053. PubMed ID: 28344058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid monitoring of immune reconstitution after allogeneic stem cell transplantation--a comparison of different assays for the detection of cytomegalovirus-specific T cells.
    Abu-Khader A; Krause S
    Eur J Haematol; 2013 Dec; 91(6):534-45. PubMed ID: 23952609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistence of recipient-derived as well as donor-derived clones of cytomegalovirus pp65-specific cytotoxic T cells long after allogeneic hematopoietic stem cell transplantation.
    Terasako-Saito K; Nakasone H; Tanaka Y; Yamazaki R; Sato M; Sakamoto K; Ishihara Y; Kawamura K; Akahoshi Y; Hayakawa J; Wada H; Harada N; Nakano H; Kameda K; Ugai T; Yamasaki R; Ashizawa M; Kimura SI; Kikuchi M; Tanihara A; Kanda J; Kako S; Nishida J; Kanda Y
    Transpl Infect Dis; 2014 Dec; 16(6):930-40. PubMed ID: 25430567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-cell T-cell receptor-β analysis of HLA-A*2402-restricted CMV- pp65-specific cytotoxic T-cells in allogeneic hematopoietic SCT.
    Nakasone H; Tanaka Y; Yamazaki R; Terasako K; Sato M; Sakamoto K; Yamasaki R; Wada H; Ishihara Y; Kawamura K; Machishima T; Ashizawa M; Kimura SI; Kikuchi M; Tanihara A; Kanda J; Kako S; Nishida J; Kanda Y
    Bone Marrow Transplant; 2014 Jan; 49(1):87-94. PubMed ID: 23933763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reconstitution of cytomegalovirus specific T cells after pediatric allogeneic stem cell transplantation: results from a pilot study using a multi-allele CMV tetramer group.
    Koehl U; Dirkwinkel E; Koenig M; Erben S; Soerensen J; Bader P; Doerr HW; Preiser W; Weissinger E; Klingebiel T; Martin H; Lehrnbecher T
    Klin Padiatr; 2008; 220(6):348-52. PubMed ID: 18949669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell receptor repertoire of cytomegalovirus-specific cytotoxic T-cells after allogeneic stem cell transplantation.
    Toya T; Taguchi A; Kitaura K; Misumi F; Nakajima Y; Otsuka Y; Konuma R; Adachi H; Wada A; Kishida Y; Konishi T; Nagata A; Yamada Y; Marumo A; Noguchi Y; Yoshifuji K; Mukae J; Inamoto K; Igarashi A; Najima Y; Kobayashi T; Kakihana K; Ohashi K; Suzuki R; Nagamatsu T; Doki N
    Sci Rep; 2020 Dec; 10(1):22218. PubMed ID: 33335252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tetramer monitoring to assess risk factors for recurrent cytomegalovirus reactivation and reconstitution of antiviral immunity post allogeneic hematopoietic stem cell transplantation.
    Borchers S; Luther S; Lips U; Hahn N; Kontsendorn J; Stadler M; Buchholz S; Diedrich H; Eder M; Koehl U; Ganser A; Mischak-Weissinger E
    Transpl Infect Dis; 2011 Jun; 13(3):222-36. PubMed ID: 21585633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential anti-cytomegalovirus response monitoring may allow prediction of cytomegalovirus reactivation after allogeneic stem cell transplantation.
    Borchers S; Bremm M; Lehrnbecher T; Dammann E; Pabst B; Wölk B; Esser R; Yildiz M; Eder M; Stadler M; Bader P; Martin H; Jarisch A; Schneider G; Klingebiel T; Ganser A; Weissinger EM; Koehl U
    PLoS One; 2012; 7(12):e50248. PubMed ID: 23272059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of cytotoxic function of CMV-pp65-specific CD8+ T-lymphocytes identified by HLA tetramers in recipients and donors of stem-cell transplants.
    Lacey SF; Gallez-Hawkins G; Crooks M; Martinez J; Senitzer D; Forman SJ; Spielberger R; Zaia JA; Diamond DJ
    Transplantation; 2002 Sep; 74(5):722-32. PubMed ID: 12352893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective immunity transferred by infusion of cytomegalovirus-specific CD8(+) T cells within donor grafts: its associations with cytomegalovirus reactivation following unmanipulated allogeneic hematopoietic stem cell transplantation.
    Luo XH; Huang XJ; Liu KY; Xu LP; Liu DH
    Biol Blood Marrow Transplant; 2010 Jul; 16(7):994-1004. PubMed ID: 20167279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reconstitution of HLA-A*2402-restricted cytomegalovirus-specific T-cells following stem cell transplantation.
    Gondo H; Himeji D; Kamezaki K; Numata A; Tanimoto T; Takase K; Aoki K; Henzan H; Nagafuji K; Miyamoto T; Ishikawa F; Shimoda K; Inaba S; Tsukamoto H; Horiuchi T; Nakashima H; Otsuka T; Kato K; Kuroiwa M; Higuchi M; Shibuya T; Kamimura T; Kuzushima K; Tsurumi T; Kanda Y; Harada M
    Int J Hematol; 2004 Dec; 80(5):441-8. PubMed ID: 15646657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitive detection of human cytomegalovirus peptide-specific cytotoxic T-lymphocyte responses by interferon-gamma-enzyme-linked immunospot assay and flow cytometry in healthy individuals and in patients after allogeneic stem cell transplantation.
    Hebart H; Daginik S; Stevanovic S; Grigoleit U; Dobler A; Baur M; Rauser G; Sinzger C; Jahn G; Loeffler J; Kanz L; Rammensee HG; Einsele H
    Blood; 2002 May; 99(10):3830-7. PubMed ID: 11986243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cytomegalovirus-specific T cells immune reconstitution after human leukocyte antigen matched sibling donor allogeneic bone marrow plus peripheral blood hematopoietic stem cell transplantation].
    Luo XH; Chang YJ; Huo MR; Li D; Huang XJ
    Zhonghua Xue Ye Xue Za Zhi; 2012 Aug; 33(8):605-9. PubMed ID: 23134850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of cytomegalovirus-specific T-cell reconstitution in patients after various allogeneic haematopoietic stem cell transplantation using interferon-gamma-enzyme-linked immunospot and human leucocyte antigen tetramer assays with an immunodominant T-cell epitope.
    Ohnishi M; Sakurai T; Heike Y; Yamazaki R; Kanda Y; Takaue Y; Mizoguchi H; Kawakami Y
    Br J Haematol; 2005 Nov; 131(4):472-9. PubMed ID: 16281937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytomegalovirus (CMV) infections and CMV-specific cellular immune reconstitution following reduced intensity conditioning allogeneic stem cell transplantation with Alemtuzumab.
    Lamba R; Carrum G; Myers GD; Bollard CM; Krance RA; Heslop HE; Brenner MK; Popat U
    Bone Marrow Transplant; 2005 Nov; 36(9):797-802. PubMed ID: 16151431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct visualization of cytomegalovirus-specific T-cell reconstitution after allogeneic stem cell transplantation.
    Cwynarski K; Ainsworth J; Cobbold M; Wagner S; Mahendra P; Apperley J; Goldman J; Craddock C; Moss PA
    Blood; 2001 Mar; 97(5):1232-40. PubMed ID: 11222365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA tetramers and anti-CMV immune responses: from epitope to immunotherapy.
    Chen FE; Aubert G; Travers P; Dodi IA; Madrigal JA
    Cytotherapy; 2002; 4(1):41-8. PubMed ID: 11953040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytomegalovirus-specific cytotoxic T lymphocytes can be efficiently expanded from granulocyte colony-stimulating factor-mobilized hemopoietic progenitor cell products ex vivo and safely transferred to stem cell transplantation recipients to facilitate immune reconstitution.
    Clancy LE; Blyth E; Simms RM; Micklethwaite KP; Ma CK; Burgess JS; Antonenas V; Shaw PJ; Gottlieb DJ
    Biol Blood Marrow Transplant; 2013 May; 19(5):725-34. PubMed ID: 23380344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.